Some information on this page may be available only to Healthcare Professionals.
Research Trials at the National Cancer Centre Singapore
The National Cancer Centre Singapore (NCCS) is a leading national and regional tertiary cancer centre that attends to 65 per cent of all cancer cases in the public sector in Singapore. In addition to offering world class cancer care, our clinicians work closely with our scientists who conduct robust, cutting-edge clinical and translational research with local and international collaboration.
Clinical trials are the best way to improve treatment outcomes for cancer and NCCS is leading the way with dynamic clinical trials aimed at developing novel and innovative treatments for all cancer types. With over two decades of experience, the Clinical Trials Office of the Humphrey Oei Institute of Cancer Research has conducted more than 450 phase I to III clinical trials to date and currently oversees more than 200 ongoing trials at NCCS.
Clinical trials at NCCS are focused on evaluating the effectiveness of novel molecular targeted agents and next generation immunotherapy approaches, while implementing the use of new technologies and digital medicine tools. Biostatistical research and epidemiological surveys are also conducted to assess real-time patient experience. NCCS has multiple active bio-pharma and bio-tech collaborations for clinical and translational research, creating a pipeline to take effective treatments to market and give new hope to individuals with cancer.